Optimization of hydroxyurea in sickle cell disease in Brazil
Despite sickle cell disease (SCD) being a well-recognized and highly prevalent condition identified early through neonatal screening programs, it represents a substantial public health challenge due to high morbidity and premature mortality rates. Hydroxyurea (HU) is the only available disease-modif...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2025-04-01
|
| Sarja: | Hematology, Transfusion and Cell Therapy |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S253113792500094X |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|